These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25272295)

  • 21. MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors.
    Markowski DN; Huhle S; Nimzyk R; Stenman G; Löning T; Bullerdiek J
    Genes Chromosomes Cancer; 2013 Mar; 52(3):297-304. PubMed ID: 23225304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
    Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A
    Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.
    Ravegnini G; Mariño-Enriquez A; Slater J; Eilers G; Wang Y; Zhu M; Nucci MR; George S; Angelini S; Raut CP; Fletcher JA
    Mod Pathol; 2013 May; 26(5):743-9. PubMed ID: 23222489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
    Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
    Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
    Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
    Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.
    Wu X; Serna VA; Thomas J; Qiang W; Blumenfeld ML; Kurita T
    Cancer Res; 2017 Dec; 77(24):6891-6901. PubMed ID: 29055020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1.
    Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P
    Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas.
    Park MJ; Shen H; Kim NH; Gao F; Failor C; Knudtson JF; McLaughlin J; Halder SK; Heikkinen TA; Vahteristo P; Al-Hendy A; Schenken RS; Boyer TG
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4283-4292. PubMed ID: 30099503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.
    Asano R; Asai-Sato M; Matsukuma S; Mizushima T; Taguri M; Yoshihara M; Inada M; Fukui A; Suzuki Y; Miyagi Y; Miyagi E
    Fertil Steril; 2019 Jan; 111(1):178-185. PubMed ID: 30554729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
    Je EM; Kim MR; Min KO; Yoo NJ; Lee SH
    Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
    Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
    Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
    Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
    J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
    Di Tommaso S; Tinelli A; Malvasi A; Massari S
    Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.
    Zhang P; Zhang C; Hao J; Sung CJ; Quddus MR; Steinhoff MM; Lawrence WD
    Hum Pathol; 2006 Oct; 37(10):1350-6. PubMed ID: 16949924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.
    Kämpjärvi K; Kim NH; Keskitalo S; Clark AD; von Nandelstadh P; Turunen M; Heikkinen T; Park MJ; Mäkinen N; Kivinummi K; Lintula S; Hotakainen K; Nevanlinna H; Hokland P; Böhling T; Bützow R; Böhm J; Mecklin JP; Järvinen H; Kontro M; Visakorpi T; Taipale J; Varjosalo M; Boyer TG; Vahteristo P
    Prostate; 2016 Jan; 76(1):22-31. PubMed ID: 26383637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of MED12 Mutation in Relation to Tumor and Patient's Clinical Characteristics: a Meta-analysis.
    He C; Nelson W; Li H; Xu YD; Dai XJ; Wang YX; Ding YB; Li YP; Li T
    Reprod Sci; 2022 Feb; 29(2):357-365. PubMed ID: 33569750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.
    Mello JBH; Barros-Filho MC; Abreu FB; Cirilo PDR; Domingues MAC; Pontes A; Rogatto SR
    Mol Hum Reprod; 2018 Nov; 24(11):556-563. PubMed ID: 30376129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
    Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
    Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients.
    Sadeghi S; Khorrami M; Amin-Beidokhti M; Abbasi M; Kamalian Z; Irani S; Omrani M; Azmoodeh O; Mirfakhraie R
    Tumour Biol; 2016 Feb; 37(2):1567-71. PubMed ID: 26298726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth.
    Bloch J; Holzmann C; Koczan D; Helmke BM; Bullerdiek J
    Oncotarget; 2017 May; 8(21):34762-34772. PubMed ID: 28410233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.